In this RH Reality Check opinion piece, Matthew Kavanagh, director of U.S. advocacy at Health GAP (Global Access Project), and Dazon Dixon Diallo, founder and president of SisterLove, Incorporated, write, "With proof that treatment is prevention, and with this basket of broader prevention options, scientists and economists have finally been able to show what few could before: models of how we end the AIDS crisis."
"A revolutionized response to the global AIDS crisis has just been made possible with the August publication of a U.S.-funded study showing that antiretroviral AIDS medicines (ARVs) can cut the risk of HIV transmission from an infected to a non-infected partner by 96 percent," the authors write, adding, "[T]his why we have launched the 96% Campaign to ask the President to pay attention to the science and pay attention to what people living with HIV need. Treatment is only one piece of the puzzle, but it is among the bedrock pieces" (10/7).
Back to other news for October 2011
This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy